Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection

Virology

Volumn 222, Issue 2, 1996, Pages 339-351

  Alin, Kimona ^a   Goff, Stephen P ^a  

^a Columbia University P and S ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS REPLICATION;

EID: 0030586691     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0431     Document Type: Article

References (48)

1. Alin, K., and Goff, S. P. (1996). Mutational analysis of interactions between the Gag precursor proteins of murine leukemia viruses. Virollogy 216, 418-424.
2. Arcement, L., Karshin, W., Naso, R., Jamjoom, G., and Arlinghaus, R. (1976). Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides. Virology 69, 763-774.
3. Arcement, L. J., Karshin, W. I., Naso, R. B., and Arlinghaus, R. B. (1977). "Gag" polyprotein precursors of Rauscher murine leukemia virus. Virology 81, 284-297.
4. Berkowitz, R. D., and Goff, S. P. (1993). Point mutations in Moloney murine leukemia virus envelope protein: Effects on infectivity, virion association, and superinfection resistance. Virology 196, 748-757.
5. Blain, S. W., and Goff, S. P. (1995). Effects on DNA synthesis and translocation caused by mutations in the RNase H domain of Moloney murine leukemia virus reverse transcriptase. J. Virol. 69, 4440-4452.
6. Bolognesi, D. P., Luftig, R., and Shaper, J. H. (1973). Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures. Virology 56, 549-564.
7. Burnette, W. N., Holladay, L. A., and Mitchell, W. M. (1976). Physical and chemical properties of Moloney Murine Leukemia Virus p30 protein: a major core structural component exhibiting high helicity and self-association. J. Mol. Biol. 107, 131-143.
8. Carrierre, C., Gay, B., Chazal, N., Morin, N., and Boulanger, P. (1995). Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles. J. Virol. 69, 2366-2377.
9. Chazal, N., Carriere, C., Gay, B., and Boulanger, P. (1994). Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells. J. Virol. 68, 111-22.
10. Colicelli, J., and Goff, S. P. (1988). Sequence and spacing requirements of a retrovirus integration site. J. Mol. Biol. 199, 47-59.
11. Craven, R. C., Leure-duPree, A. E., Weldon, R. A. J., and Wills, J. W. (1995). Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol. 69, 4213-4227.
12. Crawford, S., and Goff, S. P. (1984). Mutations in gag proteins p12 and p15 of Moloney murine leukemia virus block early stages of infection. J. Virol. 49, 909-917.
13. Cullen, B. (1987). Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152, 684-704.
14. DesGroseillers, L., and Jolicoeur, P. (1983). Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses. J. Virol. 48, 685-696.
15. Dorfman, T., Bukovsky, A., Ohagne, A., Hoglund, S., and Gottlinger, H. G. (1994). Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68, 8180-8187.
16. Gilboa, E., Mitra, S. W., Goff, S. P., and Baltimore, D. (1980). A detailed model of reverse transcription and tests of crucial aspects. Cell 18, 93-100.
17. Goff, S. P., Traktman, P., and Baltimore, D. (1981). Isolation and properties of Moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38, 239-248.
18. Granowitz, C., and Goff, S. P. (1994). Substitution mutations affecting a small region of the Moloney murine leukemia virus MA Gag protein block assembly and release of virion particles. Virology 205, 336-344.
19. Hansen, M., Jelinek, L., Whiting, S., and Barklis, E. (1990). Transport and assembly of gag proteins into Moloney murine leukemia virus. J. Virol. 64, 5306-5316.
20. Hansen, M. S., and Barklis, E. (1995). Structural interactions between retroviral Gag proteins examined by cysteine crosslinking. J. Virol. 69, 1150-1159.
21. Hirt, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-371.
22. Hong, S. S., and Boulanger, P. (1993). Assembly-defective point mutations of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells. J. Virol. 67, 2787-2798.
23. Hsu, H.-W., Schwartzberg, P., and Goff, S. P. (1985). Point mutations in the p30 domain of the gag gene of Moloney leukemia virus. Virology 142, 211-214.
24. Jolicoeur, P. (1979). The Fv-1 gene of the mouse and its control of murine leukemia virus replication. Curr. Top. Microbiol. Immunol. 86, 67-122.
25. Jones, T. A., Blaug, G., Hansen, M., and Barklis, E. (1990). Assembly of gag-β-galactosidase proteins into retrovirus particles. J. Virol. 64, 2265-2279.
26. Jowett, J. B., Hockley, D. J., Nermut, M. V., and Jones, I. M. (1992). Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation. J. Gen. Virol. 73, 3079-3086.
27. Mammano, F., Ohagen, A., Hoglund, S., and Gottlinger, H. G. (1994). Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 68, 4927-4936.
28. McCutchan, J. H., and Pagano, J. S. (1968). Enhancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyldextran. J. Natl. Cancer Inst. 41, 351-357.
29. Meric, C., and Goff, S. P. (1989). Characterization of Moloney murine leukemia virus mutants with single amino acid substitutions in the cys-his box of the nucleocapsid protein (NC). J. Virol. 63, 1558-1568.
30. Ou, C.-Y., Boone, L.R., Koh, C.K., Tennant, R. W., and Yang, W. K. (1983). Nucleotide sequences of gag-pol regions that determine the Fv-1 host range property of BALB/c N-tropic and B-tropic murine leukemia viruses. J. Virol. 48, 779-784.
31. Peden, K. W. C., and Nathans, D. (1982). Local mutagenesis within deletion loops of DNA heteroduplexes. Proc. Natl. Acad. Sci. USA 79, 7214-7217.
32. Peicin, A., Paik, S., Berkowitz, R.D., Luban, J., Lowy, I., and Goff, S. P. (1995). Linker insertion mutations in the HIV-1 gag gene: Effects on virion particle assembly, release, and infectivity. J. Virol. 69, 642-650.
33. Rothenberg, E., and Baltimore, D. (1977). Increased length of DNA made by virions of murine leukemia virus at limiting magnesium ion concentrations. J. Virol. 21, 168-178.
34. Rothenberg, E., Smotkin, D., Baltimore, D., and Weinberg, R. A. (1977). In vitro synthesis of infectious DNA of murine leukemia virus. Nature 269, 122-126.
35. Schwartzberg, P., Colicelli, J., Gordon, M. L., and Goff, S. P. (1984). Mutations in the gag gene of Moloney murine leukemia virus: effects on production of virions and reverse transcriptase. J. Virol. 49, 918-924.
36. Shields, A., Witte, O. N., Rothenberg, E., and Baltimore, D. (1978). High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections. Cell 14, 601-609.
37. Southern, P. J., and Berg, P. (1982). Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1, 327-341.
38. Srinivasakumar, N., Hammarskjold, M.-L., and Rekosh, D. (1995). Characterization of deletion mutants in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J. Virol. 69, 6106-6114.
39. Strambio-de-Castillia, C., and Hunter, E. (1992). Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J. Virol. 66, 7021-7032.
40. Telesnitsky, A., and Goff, S. P. (1993). Strong stop strand transfer during reverse transcription. In "Reverse Transcriptase" (A. M. Skalka and S. P. Goff, Eds.), pp. 49-83. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
41. van Zaane, D., Dekker-Michielsen, M. J. A., and Bloemers, H. P. J. (1976). Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus: Synthesis, identification, and processing. Virology 75, 113-129.
42. gag polyprotein essential for particle formation. Virology 193, 981-985.
43. Wang, C., and Barklis, E. (1993). Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J. Virol. 67, 4264-4273.
44. Wang, C.-T., Stegeman-Olsen, J., Zhang, Y., and Barklis, E. (1994). Assembly of HIV GAG-B-Galactosidase fusion proteins into virus particles. J. Virol. 200, 524-534.
45. Weldon, R. A., Jr., and Wills, J. W. (1993). Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release. J. Virol. 67, 5550-5561.
46. Wigler, M., Sweet, R., Sim, G. K., Wold, B., Pellicer, A., Lacy, E., Maniatis, T., Silverstein, S., and Axel, R. (1979). Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16,777-785.
47. Wills, J. W., Cameron, C. E., Wilson, C. B., Xiang, Y., Bennett, R. P., and Leis, J. (1994). An assembly domain of the Rous Sarcoma Virus Gag protein required late in budding. J. Virol. 68, 6605-6618.
48. Wills, J. W., and Craven, R. C. (1991). Form, function, and use of retroviral gag proteins. AIDS 5, 639-654.